What are the differences between hypertrophic scars and keloids, and what are the preferred treatment approaches for each?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypertrophic Scars vs Keloids: Key Differences and Treatment

Clinical Distinction

The fundamental difference is that keloids grow beyond the original wound boundaries with horizontal extension into surrounding normal skin, while hypertrophic scars remain confined within the original injury site. 1

Defining Characteristics

Keloids:

  • Extend beyond the borders of the original wound with horizontal growth into normal tissue 1
  • Can develop from minor trauma (acne, ear piercing) or severe injuries 2
  • Higher recurrence rates after excision alone (45-100%) 3
  • More resistant to treatment 4

Hypertrophic Scars:

  • Remain within the boundaries of the original wound 1
  • Result from excessive collagen deposition without horizontal spread 5
  • Better response to conservative therapies 4
  • Lower recurrence rates with appropriate treatment 3

Histopathological Features

Both conditions show excessive collagen deposition and increased glycosaminoglycan content with elevated collagen turnover 3. Keloidal collagen patterns are the strongest histological marker for keloids, though dermal nodules and α-SMA immunoreactivity are not exclusive to hypertrophic scars 1. The histopathological distinction is less straightforward than clinical appearance, with differences being more quantitative than qualitative 1.

Treatment Approach

First-Line Therapy for Both Conditions

Intralesional triamcinolone acetonide (10-40 mg/mL) is the primary treatment, with 40 mg/mL concentrations recommended for both hypertrophic scars and keloids. 6 This works by decreasing connective tissue components and reducing scar volume 3. Post-operative steroid injections reduce keloid recurrence to less than 50% 3.

Monitor for local adverse effects including atrophy, pigmentary changes, telangiectasias, and hypertrichosis, as well as systemic absorption with repeated injections. 6

Additional Conservative Therapies

Silicone-based occlusive dressings provide benefit through occlusion and hydration rather than the silicone itself 3. These are effective for both scar types 5, 4.

Pressure therapy reduces scar height through local tissue hypoxia and is proven effective for hypertrophic scars 3. Compression garments are particularly useful for large surface areas 5.

Cryotherapy is most effective when combined with intralesional corticosteroids 3. This combination approach shows superior results compared to either modality alone 4.

Surgical Considerations

Simple excision alone results in 45-100% recurrence and should never be performed without adjunct therapy. 3 Excision must be combined with:

  • Post-operative intralesional corticosteroids 3
  • Radiation therapy using various protocols for safe and efficacious recurrence reduction 3
  • Immediate post-excision adjuvant treatment 4

Emerging and Alternative Therapies

Imiquimod upregulates interferons that inhibit collagen production by fibroblasts 6, offering a newer treatment option.

Intralesional interferon (gamma and alpha-2b) successfully decreases scar height and reduces post-operative recurrences 3.

Pulsed-dye laser offers symptomatic improvement and reduces erythema associated with these scars 3, while CO2, Nd:YAG, and Argon lasers serve as destructive modalities 3.

Intralesional bleomycin and 5-fluorouracil have shown efficacy in treating abnormal scars 5, 4.

Prevention Strategy

Prevention remains the best strategy—individuals with personal or family history of keloids should be cautioned about any procedures causing skin trauma and should avoid nonessential surgery. 6, 4 This is particularly critical for keloid-prone patients, as treatment is challenging and recurrence rates are high 4.

Infection Management

Watch for secondary infections in treated scars, which can be managed with standard topical or systemic antibiotics 6.

Critical Clinical Pitfall

The most common error is treating keloids and hypertrophic scars with excision alone without adjuvant therapy, leading to near-certain recurrence 3. Always combine surgical intervention with corticosteroid injections, radiation, or other adjuvant modalities 4, 3.

References

Research

The treatment of hypertrophic scars and keloids.

European journal of dermatology : EJD, 1998

Research

Hypertrophic scars and keloids: etiology and management.

American journal of clinical dermatology, 2003

Research

Update on hypertrophic scar treatment.

Clinics (Sao Paulo, Brazil), 2014

Guideline

Keloid Management: Treatment Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.